Where does Immatics Biotechnologies GmbH rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Immatics Biotechnologies GmbH ranks #648 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Immatics Biotechnologies GmbH hold?

Immatics Biotechnologies GmbH holds 690 US utility patents granted between 2015 and 2025, spanning 15 technology areas.

What is Immatics Biotechnologies GmbH's Innovation Score?

Immatics Biotechnologies GmbH has an Innovation Score of 51.0 out of 100 (top 12% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Immatics Biotechnologies GmbH focus on?

Immatics Biotechnologies GmbH's top technology area is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes) with 680 patents, ranking #11 of 7,163 assignees active in that subclass. Grants appear in 15 CPC subclasses total.

Is Immatics Biotechnologies GmbH's patent grant rate increasing or decreasing?

Immatics Biotechnologies GmbH's recent grant velocity is +124% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Immatics Biotechnologies GmbH's patents?

Immatics Biotechnologies GmbH's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Immatics Biotechnologies GmbH patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Immatics Biotechnologies GmbH

USPTO PatentsView assignee record - 690 granted patents across 15 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Immatics ranks #648 of 49,997 tracked US assignees by granted-patent volume, with 690 patents across 15 technology areas.

#648
of 49,997 US assignees by volume: Top 12%
by Innovation Score (51.0/100): 18.8
avg claims per patent: +124%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R648 · Foreign Corporation #648 · 690 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-MID 690 grants
TOP-DECILE #648/49,997
PHOTO-FINISH Rivian IP Holdings
CPC-FOCUS A61K · 15 areas
INNOV-PAR 51.0/100
CLAIMS-RICH 18.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +124% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Rivian IP Holdings, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Immatics’s 51.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 22.6 pts (44%) Velocity 3.5 pts (7%) Breadth 13.7 pts (27%) Claim depth 11.3 pts (22%)

Qualcomm Incorporated · highest

85
Immatics Biotechnolo… · this assignee

51
Nile Global · near

51
Titan Medical · near

51
Parade · near

51
THE Board OF… · near

51
3D Lighting… · lowest

7

What this shows Immatics's Innovation Score is 51.0/100 (top 12% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Immatics?

Each dot is one of Immatics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Immatics’s own 18.8 claims/patent is ABOVE the 15.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Immatics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Immatics's grants concentrate

Immatics Biotechnologies GmbH is a focused PatentsView assignee: 15 CPC subclasses with 98.6% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (128 grants) versus a trough of 6 in 2016. By volume, Immatics sits between Cameron International Corporation and The Research Foundation for The State University of New York.

Immatics's three-year grant acceleration

From 2019–2021 to 2022–2024, Immatics Biotechnologies GmbH moved from 367 to 194 grants (0.53x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #2,625. See the growth leaderboard.

Cameron Internati…

692
Posco

691
Schneider Electri…

691
University of Was…

691
Rivian IP Holdings

690
Immatics Biotechn… ◀

690
Carl Zeiss Meditec

689
Saturn Licensing

689
The Research Foun…

688

What this shows Immatics holds 690 patents at rank #648, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immatics

By rank, the assignees closest to #648 in granted patent volume.

Leaders in A61K (Preparations FOR Medical)

Other assignees with the most granted patents in Immatics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Immatics, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Immatics ranks #11 of 7,163 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (51 here).

Titan Medical Inc. 51 Nile Global, Inc. 51 Parade Technologies, Ltd. 51 THE Board OF Regents OF THE Nevada System OF Higher Education ON Behalf OF THE University OF Nevada, LAS Vegas 51

Similar claim depth

Nearest assignees by average claims per patent (18.8 here).

Motorola Mobility LLC 18.8 avg Alibaba Group Holding Limited 18.8 avg Icahn School OF Medicine AT Mount Sinai 18.8 avg Stripe, Inc. 18.8 avg

Immatics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

51 Top 12% higher than 88% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Immatics Biotechnologies GmbH patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	8	1.2%
2016	6	0.9%
2017	7	1.0%
2018	63	9.1%
2019	115	16.7%
2020	128	18.6%
2021	124	18.0%
2022	64	9.3%
2023	51	7.4%
2024	79	11.4%
2025partial year	45	6.5%

Which technologies does Immatics Biotechnologies GmbH patent most?

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 680

C07K - Peptides 678

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 651

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 647

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 395

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 286

C12Y - Enzymes 117

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 107

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 53

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 42

Y02A - Technologies FOR Adaptation TO Climate Change 16

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 14

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 8

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 3

Y10T - Technical Subjects Covered BY Former US Classification 2

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Immatics Biotechnologies GmbH's patent record in context - here's where to go next.

Immatics Biotechnologies GmbH's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 98.6% of its portfolio - see every assignee active in that class. Explore A61K
Ranked #648 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Immatics Biotechnologies GmbH against Cameron International Corporation, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 51.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.